Applicant, as named in the Orange Book

Melinta

Next listed expiry: Baxdela on 19 Jun 2031. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Baxdela delafloxacin meglumine	delafloxacin meglumine	208610	19 Jun 2031	patent
Baxdela delafloxacin meglumine	delafloxacin meglumine	208611	2 Jun 2034	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.